Navigation Links
Low Vitamin D Linked to Deterioration in Certain Leukemia Patients
Date:11/12/2010

FRIDAY, Nov. 12 (HealthDay News) -- Patients with a certain type of leukemia who had insufficient vitamin D levels when their cancer was diagnosed saw their disease progress much faster and were two times more likely to die than those with adequate vitamin D levels, a new study finds.

Researchers also discovered that increasing vitamin D levels in patients was linked to longer survival times, even after controlling for other factors associated with leukemia progression.

This is an important finding for both patients and doctors, according to the researchers at the Mayo Clinic in Rochester, Minn. and the University of Iowa.

The disease -- chronic lymphocytic leukemia (CLL) -- is cancer of the white blood cells (lymphocytes) and mainly affects adults. Although CLL is often diagnosed at an early stage, the standard approach is to wait until patients develop symptoms before beginning chemotherapy, explained study author and hematologist Dr. Tait Shanafelt.

"This watch-and-wait approach is difficult for patients because they feel there is nothing they can do to help themselves," Shanafelt said in a Mayo news release. "It appears vitamin D levels may be a modifiable risk factor for leukemia progression. It is simple for patients to have their vitamin D levels checked by their physicians with a blood test. And if they are deficient, vitamin D supplements are widely available and have minimal side effects."

This study of 390 CLL patients found that 30 percent of them had insufficient vitamin D levels (less than 25 nanograms per milliliter) at the time of cancer diagnosis. After a median follow-up of three years, patients with insufficient vitamin D levels were 66 percent more likely to have disease progression and to require chemotherapy. They also had a twofold increased risk of death, compared to those with adequate vitamin D levels.

Similar findings were seen in a different group of CLL patients who were followed for 10 years, according to the researchers.

"This tells us that vitamin D insufficiency may be the first potentially modifiable risk factor associated with prognosis in newly diagnosed CLL," Shanafelt said.

The researchers are planning another study to see if reversing low vitamin D levels in patients will improve their prognosis.

The study appears online in the journal Blood.

More information

The Leukemia and Lymphoma Society has more about chronic lymphocytic leukemia.

-- Robert Preidt

SOURCE: Mayo Clinic, news release, Nov. 4, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Study Finds Vitamins E and C Dont Reduce Cataract Risk in Men
2. Vitamin D No Magic Bullet for Osteoarthritis
3. Vitamin E May Pose Slight Bleeding-Stroke Risk
4. Insufficient vitamin D levels in CLL patients linked to cancer progression and death
5. Genetics May Play Role in Vitamin E Levels
6. New clinical trial explores role of vitamin D in preventing esophageal cancer
7. Vigilance Against Skin Cancer May Lead to Lack of Vitamin D
8. Vitamin D deficiency linked to lung transplant rejection
9. Can Vitamin B12 Reduce Alzheimers Risk?
10. Vitamin D-ficiency common among orthopaedic surgery
11. Using cassava to address vitamin A deficiency
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Low Vitamin D Linked to Deterioration in Certain Leukemia Patients
(Date:4/28/2017)... ... April 28, 2017 , ... Somnoware, a leading ... Word(TM) Online(TM), which enables sleep physicians to create and edit their interpretation reports. ... and provides a familiar interface that does not require additional training to use. ...
(Date:4/28/2017)... Grants Pass, OR (PRWEB) , ... April 28, ... ... Adetutu Ijose, http://www.foodsthathealdaily.com , http://www.wiredlifesolutions.com , “Computers are everywhere and ... Kleyne Hour Power of Water, Global Climate Change and Your Health on Voice ...
(Date:4/28/2017)... ... April 28, 2017 , ... The Texas Cord Blood ... to the labor and delivery team at Women’s Hospital at Renaissance in Edinburg for ... birth at the hospital and decide to donate. , “Women’s Hospital at Renaissance ...
(Date:4/28/2017)... ... ... Pastor and Overseer at The House of Yahweh in Abilene, Texas, has published a new ... not. Yisrayl says with so many titles and names for the Creator, it’s hard ... a little Scripture, backed with a lot of research, the truth is undeniable. , ...
(Date:4/28/2017)... , ... April 28, 2017 , ... NuevaCare, a leading ... diverse as Millbrae, Burlingame, and Palo Alto, is proud to announce information upgrades to ... to bookmark and read organized content on topics such as home care (generally) as ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... --  ZappRx, Inc ., a digital health company focused on ... it closed $25 million in Series B funding led by ... Seattle that is part of a ... B round included participation from SR One , who ... (formerly Google Ventures). As part of the financing, ...
(Date:4/20/2017)... , April 20, 2017 Eyevensys, ... the first non-viral gene expression technology that enables the ... eye to address a wide range of ophthalmic diseases, ... and Healthcare products Regulatory Agency (MHRA) to advance its ... ...
Breaking Medicine Technology: